SYRE - CIK 0001636282
Spyre Therapeutics, Inc. has filed 762 documents with the SEC between 2015 and 2026. The most frequent type is insider trade (195 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2026-05-08 | - |
| Insider trade | 4 | 2026-05-08 | 2026-05-08 |
| Major company event | 8-K | 2026-05-05 | 2026-05-05 |
| Quarterly report | 10-Q | 2026-05-05 | 2026-03-31 |
| Insider trade | 4 | 2026-05-01 | 2026-05-01 |
| Insider sale notice | 144 | 2026-05-01 | - |
| Insider sale notice | 144 | 2026-05-01 | - |
| Insider trade | 4 | 2026-05-01 | 2026-05-01 |
| Insider trade | 4 | 2026-05-01 | 2026-05-01 |
| SCHEDULE 13G | - | 2026-04-22 | - |
| SCHEDULE 13D/A | - | 2026-04-20 | - |
| Major company event | 8-K | 2026-04-16 | 2026-04-14 |
| Prospectus supplement | 424B5 | 2026-04-16 | - |
| Prospectus supplement | 424B5 | 2026-04-13 | - |
| Major company event | 8-K | 2026-04-13 | 2026-04-13 |
| Major company event | 8-K | 2026-04-13 | 2026-04-13 |
| Annual report to shareholders | ARS | 2026-04-10 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-10 | - |
| Proxy statement | DEF 14A | 2026-04-10 | 2026-05-27 |
| Insider trade | 4 | 2026-04-03 | 2026-04-01 |
| Insider trade | 4 | 2026-04-03 | 2026-04-01 |
| Insider trade | 4 | 2026-04-03 | 2026-04-01 |
| Insider sale notice | 144 | 2026-04-01 | - |
| SCHEDULE 13G/A | - | 2026-03-27 | - |
| EFFECT | - | 2026-03-04 | - |
| Insider sale notice | 144 | 2026-03-03 | - |
| Insider trade | 4 | 2026-03-03 | 2026-03-03 |
| Insider trade | 4 | 2026-03-03 | 2026-03-02 |
| Insider sale notice | 144 | 2026-03-02 | - |
| EFFECT | - | 2026-02-27 | - |
| POS AM | - | 2026-02-27 | - |
| Company correspondence | CORRESP | 2026-02-25 | - |
| SEC correspondence | UPLOAD | 2026-02-25 | - |
| Employee stock plan | S-8 | 2026-02-19 | - |
| Major company event | 8-K | 2026-02-19 | 2026-02-19 |
| Annual report | 10-K | 2026-02-19 | 2025-12-31 |
| Securities registration | S-3 | 2026-02-19 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-01-23 | 2026-01-21 |
| Insider trade | 4 | 2026-01-13 | 2026-01-09 |
| Insider trade | 4 | 2026-01-13 | 2026-01-09 |
| Insider trade | 4 | 2026-01-13 | 2026-01-09 |
| Insider trade | 4 | 2026-01-13 | 2026-01-09 |
| Major company event | 8-K | 2026-01-12 | 2026-01-12 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2025-12-03 | 2025-12-01 |
| Insider trade | 4 | 2025-11-05 | 2025-11-03 |
| Major company event | 8-K | 2025-11-04 | 2025-11-04 |
| Quarterly report | 10-Q | 2025-11-04 | 2025-09-30 |